AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 26850901 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 239
Study 24517110 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinician and caregiver feedback intervention (INT)
Number of subjects: 300
Study 24517110 — intervention group
Group type: COMPARATOR
Intervention: Attention control group (CON)
Number of subjects: 300
Study 22821644 — intervention group
Group type: EXPERIMENTAL
Intervention: Telmisartan 80 mg/day (Tel80)
Number of subjects: 40
Study 22821644 — intervention group
Group type: COMPARATOR
Intervention: Telmisartan 40 mg + Amlodipine 5 mg (Tel40 + Aml5)
Number of subjects: 40
Study 20679277 — intervention group
Group type: EXPERIMENTAL
Intervention: Women's crisis house (randomised arm)
Number of subjects: 41
Study 20679277 — intervention group
Group type: COMPARATOR
Intervention: Traditional psychiatric wards (randomised arm)
Number of subjects: 41
Study 20679277 — intervention group
Group type: EXPERIMENTAL
Intervention: Women's crisis house (patient-preference arm)
Number of subjects: 41
Study 20679277 — intervention group
Group type: COMPARATOR
Intervention: Traditional psychiatric wards (patient-preference arm)
Number of subjects: 41
Study 18073543 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 ml/kg 20% mannitol
Number of subjects: 40
Study 18073543 — intervention group
Group type: COMPARATOR
Intervention: 3% hypertonic saline (HS)
Number of subjects: 40
Study 15710659 — intervention group
Group type: EXPERIMENTAL
Intervention: Osteopathic manipulative treatment (OMT)
Number of subjects: 0
Study 15710659 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study 11343005 — intervention group
Group type: EXPERIMENTAL
Intervention: Home telemonitoring (HT) plus usual care
Number of subjects: 26
Study 11343005 — intervention group
Group type: EXPERIMENTAL
Intervention: Community-based monitoring (CBM) plus usual care
Number of subjects: 26
Study 11343005 — intervention group
Group type: COMPARATOR
Intervention: Usual care only
Number of subjects: 26
Study 9273829 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcoholic beverage (0.56 g of alcohol per kg of body weight)
Number of subjects: 35
Study 9273829 — intervention group
Group type: EXPERIMENTAL
Intervention: Placebo beverage (3 mL of alcohol)
Number of subjects: 35
Study 7892777 — intervention group
Group type: EXPERIMENTAL
Intervention: Children in the clinical group (patients at a child and adolescent psychiatric clinic)
Number of subjects: 39
Study 7892777 — intervention group
Group type: COMPARATOR
Intervention: Control group (children without psychiatric issues)
Number of subjects: 39
Study 7892777 — intervention group
Group type: EXPERIMENTAL
Intervention: Parents' mental health and children's behavioral disturbances
Number of subjects: 39
Study 7892777 — intervention group
Group type: EXPERIMENTAL
Intervention: Parents' social networks and children's behavioral disturbances
Number of subjects: 39
Study 7892777 — intervention group
Group type: EXPERIMENTAL
Intervention: Parents' mental health and their social networks
Number of subjects: 39
Study 7892777 — intervention group
Group type: EXPERIMENTAL
Intervention: Parents' mental health and children's social networks
Number of subjects: 39
Study 3223489 — intervention group
Group type: EXPERIMENTAL
Intervention: Comprehensive intervention (self-help manual, televised broadcast, weekly support meetings, supportive phone calls)
Number of subjects: 100000
Study 3223489 — intervention group
Group type: COMPARATOR
Intervention: No-intervention control condition
Number of subjects: 100000
Study 2277739 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled albuterol and systemic corticosteroids
Number of subjects: 50
Study 2277739 — intervention group
Group type: COMPARATOR
Intervention: Inhaled albuterol and placebo
Number of subjects: 50
Study 54634 — intervention group
Group type: EXPERIMENTAL
Intervention: Cysteamine
Number of subjects: 38
Study 54634 — intervention group
Group type: COMPARATOR
Intervention: Control (no cysteamine)
Number of subjects: 38
Study 30318664 — intervention group
Group type: EXPERIMENTAL
Intervention: Graded in vivo exposure (Exposure)
Number of subjects: 61
Study 30318664 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-behavioural therapy (CBT)
Number of subjects: 61
Study 30318664 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 61
Study 28303470 — intervention group
Group type: EXPERIMENTAL
Intervention: Xylitol chewing gum (2.5 g/day)
Number of subjects: 179
Study 28303470 — intervention group
Group type: COMPARATOR
Intervention: Polyol chewing gum
Number of subjects: 179
Study 28303470 — intervention group
Group type: EXPERIMENTAL
Intervention: Xylitol chewing gum
Number of subjects: 179
Study 25566827 — intervention group
Group type: EXPERIMENTAL
Intervention: Hand hygiene intervention including HH products, training sessions, and posters/stickers
Number of subjects: 545
Study 25566827 — intervention group
Group type: COMPARATOR
Intervention: Control group (usual practice)
Number of subjects: 545
Study 22732766 — intervention group
Group type: EXPERIMENTAL
Intervention: Vardenafil (20, 10 or 5 mg single oral doses)
Number of subjects: 16
Study 22732766 — intervention group
Group type: COMPARATOR
Intervention: Vardenafil co-medicated with bosentan
Number of subjects: 16
Study 21310291 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention (trained family planning counselors)
Number of subjects: 906
Study 21310291 — intervention group
Group type: COMPARATOR
Intervention: Control (standard of care)
Number of subjects: 906
Study 19247776 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief lecture on anesthesia covering seven intervention questions
Number of subjects: 50
Study 19247776 — intervention group
Group type: COMPARATOR
Intervention: Control questions (seven questions not covered in the lecture)
Number of subjects: 50
Study 16759047 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate enfuvirtide/optimized‐background treatment regimen
Number of subjects: 30
Study 16759047 — intervention group
Group type: COMPARATOR
Intervention: 16‐week treatment interruption followed by enfuvirtide/optimized‐background treatment regimen
Number of subjects: 30
Study 16759047 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline phenotypic susceptibility score
Number of subjects: 30
Study 16759047 — intervention group
Group type: EXPERIMENTAL
Intervention: Enfuvirtide‐containing regimen
Number of subjects: 30
Study 16759047 — intervention group
Group type: COMPARATOR
Intervention: Treatment interruption
Number of subjects: 30
Study 15374792 — intervention group
Group type: EXPERIMENTAL
Intervention: Black patients
Number of subjects: 7179
Study 15374792 — intervention group
Group type: COMPARATOR
Intervention: Non-black patients
Number of subjects: 7179
Study 11699489 — intervention group
Group type: EXPERIMENTAL
Intervention: HTR (microporous biocompatible composite of PMMA, PHEMA and calcium hydroxide graft)
Number of subjects: 8
Study 11699489 — intervention group
Group type: EXPERIMENTAL
Intervention: ePTFE (expanded polytetrafluoroethylene barrier membrane)
Number of subjects: 8
Study 11699489 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of HTR and ePTFE
Number of subjects: 8
Study 11699489 — intervention group
Group type: COMPARATOR
Intervention: HTR alone
Number of subjects: 8
Study 11699489 — intervention group
Group type: COMPARATOR
Intervention: ePTFE alone
Number of subjects: 8
Study 11699489 — intervention group
Group type: COMPARATOR
Intervention: Combination treatment
Number of subjects: 8
Study 9155807 — intervention group
Group type: EXPERIMENTAL
Intervention: Interplak electric toothbrush
Number of subjects: 36
Study 9155807 — intervention group
Group type: EXPERIMENTAL
Intervention: Philips electric toothbrush
Number of subjects: 36
Study 9155807 — intervention group
Group type: EXPERIMENTAL
Intervention: Rotadent electric toothbrush
Number of subjects: 36
Study 9155807 — intervention group
Group type: COMPARATOR
Intervention: Manual multitufted toothbrush (Blend‐a‐Med)
Number of subjects: 36
Study 7952370 — intervention group
Group type: EXPERIMENTAL
Intervention: Home care services
Number of subjects: 415
Study 7952370 — intervention group
Group type: EXPERIMENTAL
Intervention: Independent weekly assessments
Number of subjects: 415
Study 7952370 — intervention group
Group type: EXPERIMENTAL
Intervention: Demographic and illness factors
Number of subjects: 415
Study 7952370 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychological factors assessments
Number of subjects: 415
Study 7952370 — intervention group
Group type: EXPERIMENTAL
Intervention: Preference for inpatient care
Number of subjects: 415
Study 3454893 — intervention group
Group type: EXPERIMENTAL
Intervention: Sending lists of infants due for immunisation to general practitioners
Number of subjects: 0
Study 3454893 — intervention group
Group type: EXPERIMENTAL
Intervention: Sending immunisation reminder cards to parents
Number of subjects: 0
Study 3454893 — intervention group
Group type: COMPARATOR
Intervention: Control group (comparable controls)
Number of subjects: 0
Study 31715306 — intervention group
Group type: EXPERIMENTAL
Intervention: Follistatin (FS) and soluble endoglin (sEng) levels measured at day +28 post-HCT
Number of subjects: 221
Study 31715306 — intervention group
Group type: EXPERIMENTAL
Intervention: Pre-HCT measurements of FS and sEng
Number of subjects: 221
Study 29802750 — intervention group
Group type: EXPERIMENTAL
Intervention: Pseudo-maximum likelihood estimation for site-occupancy models
Number of subjects: 0
Study 29802750 — intervention group
Group type: COMPARATOR
Intervention: Maximum likelihood estimator of species-environment relationships
Number of subjects: 0
Study 29802750 — intervention group
Group type: EXPERIMENTAL
Intervention: Simulations assessing modeling data sets
Number of subjects: 0
Study 28699886 — intervention group
Group type: EXPERIMENTAL
Intervention: IL-1 trap rilonacept (160 mg/week) for 12 weeks
Number of subjects: 39
Study 28699886 — intervention group
Group type: COMPARATOR
Intervention: Placebo for 12 weeks
Number of subjects: 39
Study 25503808 — intervention group
Group type: EXPERIMENTAL
Intervention: Day 6 recombinant FSH priming
Number of subjects: 40
Study 25503808 — intervention group
Group type: COMPARATOR
Intervention: No FSH priming
Number of subjects: 40
Study 22941967 — intervention group
Group type: EXPERIMENTAL
Intervention: Encircling ipsilateral pulmonary veins isolation (EIPVsI) with the double-Lasso technique
Number of subjects: 81
Study 22941967 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-isolation of the PV carina after EIPVsI
Number of subjects: 81
Study 22941967 — intervention group
Group type: EXPERIMENTAL
Intervention: Pacing from the PV carina
Number of subjects: 81
Study 21106014 — intervention group
Group type: EXPERIMENTAL
Intervention: Clopidogrel + PPI
Number of subjects: 49
Study 21106014 — intervention group
Group type: COMPARATOR
Intervention: Clopidogrel only
Number of subjects: 49
Study 18172922 — intervention group
Group type: EXPERIMENTAL
Intervention: Doppler ultrasound (DUS)
Number of subjects: 88
Study 16981859 — intervention group
Group type: EXPERIMENTAL
Intervention: Double-dose CEE/MPA (conjugated equine estrogens plus medroxyprogesterone acetate, 0.625 mg + 2.5 mg) daily
Number of subjects: 21
Study 16981859 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-dose CEE/MPA (0.625 mg + 2.5 mg) daily
Number of subjects: 21
Study 16981859 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21
Study 16981859 — intervention group
Group type: EXPERIMENTAL
Intervention: CEE/MPA (both doses)
Number of subjects: 21
Study 14614086 — intervention group
Group type: EXPERIMENTAL
Intervention: Right amygdala damage
Number of subjects: 61
Study 14614086 — intervention group
Group type: EXPERIMENTAL
Intervention: Left amygdala damage
Number of subjects: 61
Study 14614086 — intervention group
Group type: EXPERIMENTAL
Intervention: Bilateral amygdala damage
Number of subjects: 61
Study 14614086 — intervention group
Group type: COMPARATOR
Intervention: Normal controls
Number of subjects: 61
Study 11740262 — intervention group
Group type: EXPERIMENTAL
Intervention: G-CSF (2 microg/kg subcutaneously once a day for 5 days)
Number of subjects: 25
Study 11740262 — intervention group
Group type: COMPARATOR
Intervention: Placebo (sterilized saline)
Number of subjects: 25
Study 9652562 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-chamber atrial pacing
Number of subjects: 225
Study 7659880 — intervention group
Group type: EXPERIMENTAL
Intervention: Digoxin
Number of subjects: 31
Study 7659880 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 31
Study 3540764 — intervention group
Group type: EXPERIMENTAL
Intervention: Real Acupuncture
Number of subjects: 43
Study 3540764 — intervention group
Group type: COMPARATOR
Intervention: Placebo Acupuncture
Number of subjects: 43
Study 3540764 — intervention group
Group type: COMPARATOR
Intervention: Standard Control
Number of subjects: 43
Study 3540764 — intervention group
Group type: COMPARATOR
Intervention: Visitation Control
Number of subjects: 43
Study 30942028 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture treatment (once a day, 5 treatments a week for 4 weeks) at points Baihui (BL 20), Fengchi (GB 20), Pishu (BL 20), Shenshu (BL 23), Sanyinjiao (SP 6), Taixi (KI 3)
Number of subjects: 68
Study 30942028 — intervention group
Group type: COMPARATOR
Intervention: Control group received oryzanol and vitamin B1 with rest and physical exercise
Number of subjects: 68
Study 28426260 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 mg dapagliflozin
Number of subjects: 56
Study 28426260 — intervention group
Group type: COMPARATOR
Intervention: Cessation of dapagliflozin
Number of subjects: 56
Study 25731671 — intervention group
Group type: EXPERIMENTAL
Intervention: CABG (Isolated coronary artery bypass grafting)
Number of subjects: 2553
Study 23527721 — intervention group
Group type: EXPERIMENTAL
Intervention: Fibrin sealant
Number of subjects: 70
Study 21672213 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate insertion of intrauterine contraception after second trimester abortion
Number of subjects: 0
Study 21672213 — intervention group
Group type: COMPARATOR
Intervention: Delayed insertion of intrauterine contraception at 4 weeks post-abortion
Number of subjects: 0
Study 19491213 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily intake of a combination pill of 2.5 mg folic acid, 50 mg vitamin B6, and 1 mg vitamin B12
Number of subjects: 5242
Study 19491213 — intervention group
Group type: COMPARATOR
Intervention: Placebo group
Number of subjects: 5242
Study 16967040 — intervention group
Group type: EXPERIMENTAL
Intervention: NNRTI (efavirenz)
Number of subjects: 291
Study 16967040 — intervention group
Group type: COMPARATOR
Intervention: NRTI (stavudine)
Number of subjects: 291
Study 16967040 — intervention group
Group type: COMPARATOR
Intervention: PI (ritonavir-boosted amprenavir)
Number of subjects: 291
Study 16967040 — intervention group
Group type: EXPERIMENTAL
Intervention: All treatment regimens
Number of subjects: 291
Study 16967040 — intervention group
Group type: EXPERIMENTAL
Intervention: Abacavir (ABC)
Number of subjects: 291
Study 12739919 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutrition counseling plus a nutritional supplement (Study) for 90 days
Number of subjects: 92
Study 12739919 — intervention group
Group type: COMPARATOR
Intervention: Nutrition counseling alone (Control)
Number of subjects: 92
Study 12739919 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutrition counseling plus a nutritional supplement (Study)
Number of subjects: 92
Study 10972607 — intervention group
Group type: EXPERIMENTAL
Intervention: sufentanil-midazolam (SM)
Number of subjects: 40
Study 10972607 — intervention group
Group type: COMPARATOR
Intervention: remifentanil-propofol (RP)
Number of subjects: 40
Study 8832480 — intervention group
Group type: EXPERIMENTAL
Intervention: Flap debridement surgery + 100 mg/ml TTC solution and FFSS application
Number of subjects: 11
Study 8832480 — intervention group
Group type: COMPARATOR
Intervention: Flap debridement surgery alone (control)
Number of subjects: 11
Study 1418403 — intervention group
Group type: EXPERIMENTAL
Intervention: Immunotherapy
Number of subjects: 0
Study 1418403 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 3871235 — intervention group
Group type: EXPERIMENTAL
Intervention: Urea treatment during cardiopulmonary bypass
Number of subjects: 48
Study 3871235 — intervention group
Group type: COMPARATOR
Intervention: Control (placebo) during cardiopulmonary bypass
Number of subjects: 48
Study 30054088 — intervention group
Group type: EXPERIMENTAL
Intervention: 15.8 mm scleral lens (L1)
Number of subjects: 21
Study 30054088 — intervention group
Group type: COMPARATOR
Intervention: 18 mm scleral lens (L2)
Number of subjects: 21
Study 30054088 — intervention group
Group type: EXPERIMENTAL
Intervention: Both lenses (L1 and L2)
Number of subjects: 21
Study 30053634 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief combined parent‐based intervention (CBT‐based bibliotherapy plus doll)
Number of subjects: 68
Study 30053634 — intervention group
Group type: COMPARATOR
Intervention: Wait list control group
Number of subjects: 68
Study 27367745 — intervention group
Group type: EXPERIMENTAL
Intervention: Difluprednate 0.05% four times daily
Number of subjects: 80
Study 27367745 — intervention group
Group type: COMPARATOR
Intervention: Prednisolone acetate 1% four times daily
Number of subjects: 80
Study 27367745 — intervention group
Group type: EXPERIMENTAL
Intervention: Difluprednate 0.05%
Number of subjects: 80
Study 27367745 — intervention group
Group type: COMPARATOR
Intervention: Prednisolone acetate 1%
Number of subjects: 80
Study 25156687 — intervention group
Group type: COMPARATOR
Intervention: No information about the effects of PCI on MI risk
Number of subjects: 1257
Study 25156687 — intervention group
Group type: EXPERIMENTAL
Intervention: Specific statement that PCI does not reduce MI risk
Number of subjects: 1257
Study 25156687 — intervention group
Group type: EXPERIMENTAL
Intervention: Explanation of why PCI does not reduce MI risk
Number of subjects: 1257
Study 21901316 — intervention group
Group type: EXPERIMENTAL
Intervention: 1,017 μg salvinorin A
Number of subjects: 30
Study 21901316 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 μg salvinorin A
Number of subjects: 30
Study 21901316 — intervention group
Group type: COMPARATOR
Intervention: Placebo (control)
Number of subjects: 30
Study 20871954 — intervention group
Group type: EXPERIMENTAL
Intervention: Cervical headgear alone
Number of subjects: 60
Study 20871954 — intervention group
Group type: EXPERIMENTAL
Intervention: Cervical headgear and lower utility arch
Number of subjects: 60
Study 20871954 — intervention group
Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 60
Study 17114190 — intervention group
Group type: EXPERIMENTAL
Intervention: MM-093 (21 mg weekly subcutaneous injections)
Number of subjects: 12
Study 17114190 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 16623018 — intervention group
Group type: EXPERIMENTAL
Intervention: Diabetes drug counseling by pharmacist, diabetes booklet, and special medication containers
Number of subjects: 360
Study 16623018 — intervention group
Group type: COMPARATOR
Intervention: Diabetes drug counseling by pharmacist
Number of subjects: 360
Study 16623018 — intervention group
Group type: EXPERIMENTAL
Intervention: All interventions (drug counseling, booklet, containers)
Number of subjects: 360
Study 12131506 — intervention group
Group type: EXPERIMENTAL
Intervention: ChloraPrep (2% chlorhexidine gluconate + 70% isopropyl alcohol)
Number of subjects: 0
Study 12131506 — intervention group
Group type: COMPARATOR
Intervention: 70% isopropyl alcohol
Number of subjects: 0
Study 12131506 — intervention group
Group type: COMPARATOR
Intervention: 2% aqueous chlorhexidine
Number of subjects: 0
Study 10440120 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive diet-exercise programme
Number of subjects: 523
Study 10440120 — intervention group
Group type: COMPARATOR
Intervention: Control group (general information about lifestyle changes)
Number of subjects: 523
Study 9164416 — intervention group
Group type: EXPERIMENTAL
Intervention: Delavirdine mesylate (400 mg every 8 hours for 30 days) + Rifampin (600 mg once-daily on days 16-30)
Number of subjects: 12
Study 9164416 — intervention group
Group type: COMPARATOR
Intervention: Delavirdine mesylate (400 mg every 8 hours for 30 days)
Number of subjects: 12
Study 1774018 — intervention group
Group type: EXPERIMENTAL
Intervention: Constant rate iv infusion of insulin (0.034 U/kg/h) during 150 minutes
Number of subjects: 8
Study 1774018 — intervention group
Group type: COMPARATOR
Intervention: Identical infusion of insulin with variable iv infusion of glucose to maintain euglycemia
Number of subjects: 8
Study 7075642 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol 160 mg
Number of subjects: 10
Study 7075642 — intervention group
Group type: EXPERIMENTAL
Intervention: Sotalol 160 mg
Number of subjects: 10
Study 31399128 — intervention group
Group type: EXPERIMENTAL
Intervention: Pharmaceutical care (intervention group)
Number of subjects: 0
Study 31399128 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 0
Study 28412602 — intervention group
Group type: EXPERIMENTAL
Intervention: Medication management plus full CBT
Number of subjects: 124
Study 28412602 — intervention group
Group type: EXPERIMENTAL
Intervention: Medication management plus instructions in CBT
Number of subjects: 124
Study 28412602 — intervention group
Group type: COMPARATOR
Intervention: Medication management
Number of subjects: 124
Study 28412602 — intervention group
Group type: EXPERIMENTAL
Intervention: Child‐rated depression
Number of subjects: 124
Study 26781346 — intervention group
Group type: EXPERIMENTAL
Intervention: Mecapegfilgrastim 100 μg/kg
Number of subjects: 0
Study 26781346 — intervention group
Group type: EXPERIMENTAL
Intervention: Mecapegfilgrastim 6 mg fixed dose
Number of subjects: 0
Study 26781346 — intervention group
Group type: COMPARATOR
Intervention: Saline (control)
Number of subjects: 0
Study 26781346 — intervention group
Group type: COMPARATOR
Intervention: Daily rhG-CSF
Number of subjects: 0
Study 24963611 — intervention group
Group type: EXPERIMENTAL
Intervention: Usual care plus 6 months of telephone coaching
Number of subjects: 94
Study 24963611 — intervention group
Group type: COMPARATOR
Intervention: Usual care only
Number of subjects: 94
Study 22543063 — intervention group
Group type: EXPERIMENTAL
Intervention: PER3(5/5) genotype
Number of subjects: 279
Study 22543063 — intervention group
Group type: EXPERIMENTAL
Intervention: PER3(4/4) genotype
Number of subjects: 279
Study 22543063 — intervention group
Group type: COMPARATOR
Intervention: Overall population
Number of subjects: 279
Study 20139790 — intervention group
Group type: EXPERIMENTAL
Intervention: Active-commute (walking) group
Number of subjects: 40
Study 18589022 — intervention group
Group type: EXPERIMENTAL
Intervention: Parental feeding practices (encouraging, modeling, restriction, pressure to eat, responsibility, monitoring)
Number of subjects: 239